Search
Close this search box.
Follow us

Product

Related

Products

Tofacitinib citrate

Anti-rheumatic

Cas No: 540737-29-9

Mechanism Of Action: Tofacitinib exerts its mechanism of action by inhibiting intracellular cytoplasmic non-receptor tyrosine kinase JAK enzymes, which are involved in adaptive and innate

Riluzole

Central nervous

Cas No: 1744-22-5

Mechanism Of Action: The mode of action is unknown; it’s believe that it has inhibitory effect on glutamate release (activation of glutamate reuptake), and inactivity

molnupiravir

Covid 19

Cas No: 2349386-89-4

Mechanism Of Action: Molnupiravir is hydrolyzed in vivo to N4-hydroxycytidine, which is phosphorylated in tissue to the active 5’-triphosphate form, and incorporated into the genome of new

Favipiravir

Covid 19

Cas No: 259793-96-9

Mechanism Of Action: The active favipiravir-RTP selectively can inhibit RNA polymerase and prevent replication of the viral genome. There are several hypotheses as to how

TICAGRELOR

Cardiovascular

Cas No: 274693-27-5

Mechanism Of Action: Ticagrelor exerts its pharmacological effects by binding to a specific site on the P2Y12 receptor, which is different from the ADP binding

APIXABAN

Cardiovascular

Cas No: 503612-47-3

Mechanism Of Action: It’s a highly selective and reversible direct inhibitor of free and clot-bound factor Xa, the final enzyme in the coagulation cascade that is

Rivaroxaban

Cardiovascular

Cas No: 366789-02-8

Mechanism Of Action: It’s a selective inhibitor of factor Xa (FXa), and is an inhibitor of free FXa and prothrombinase activity, and indirectly inhibits platelet aggregation

Ozanimod Hydrochloride

Multiple Sclerosis

Cas No: 1618636-37-5

Mechanism Of Action: Ozanimod is a specific modulator of S1P receptors that selectively binds to S1P1R and S1P5R subtypes. While the exact mechanism of action

Siponimod fumarate

Multiple Sclerosis

Cas No: 1234627-85-0

Mechanism Of Action: Siponimod works through a mechanism of action as a selective modulator of sphingosine 1-phosphate receptors (S1P). Specifically, it binds to S1P subtypes

Diroximel Fumarate

Multiple Sclerosis

Cas No: 1577222-14-0

Mechanism Of Action: Diroximel fumarate is believed to modulate cell signaling pathways, leading to favorable immune and neuroprotective effects. Monomethyl fumarate (MMF) serves as the